This product is indicated for patients with high surgical risk for conventional valve replacement.
Transapical Access
For minimally invasive surgical treatment of calcifying aortic stenosis in a native valve.
For the valve-in-valve treatment of dysfunctional aortic or mitral bioprosthesis.
Transaortic Access | Procedure with CPB
For the surgical treatment of calcifying aortic stenosis in a native valve.
For the treatment of aortic bioprosthesis dysfunction.
Transaortic Access | Procedure without CPB
For the surgical treatment of calcifying aortic stenosis in a native valve.
For the treatment of aortic bioprosthesis dysfunction.